• Hero Banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Buying or Selling a Practice
Hospital Design
Leadership & Personal Growth
Personnel Management
Practice Finances
Practice Operations
Technology
Wellbeing & Lifestyle
Continuing Education
Conferences
Live Conferences
Conference News
Conference Proceedings
Resources
CBD in Pets
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Breakthrough research surrounding proprietary canine CBD+CBDA oil and atopic dermatitis

June 6, 2022
dvm360 Staff

Marks one of the few studies completed to show CBD as potential treatment for atopic dermatitis

ElleVets Sciences has announced that research findings of its CBD+CBDA oil’s efficacy on dogs with atopic dermatitis were published. The results displayed that over 65% of the dogs participating in the study had a substantial improvement in skin itchiness.1

According to a company release,2 although CBD has been widely believed to serve as a possible treatment method for atopic dermatitis, there has been little research studies before this one.

The study was led by Andrew Rosenberg, DVM, DACVM, of the Dermatology Center of New York and New Jersey, consisting of year-long research investigating a month-long treatment in a placebo blinded controlled clinical trial where dogs were either given a placebo or ElleVet Sciences' CBD+CBDA oil.1 Itchiness scores documented by owners decreased significantly for canines on the ElleVet Sciences' oil when compared to those on the placebo.

Additionally, each dog did not respond to the sesame oil base as a control group, demonstrating ElleVet Sciences’ product has a noteworthy effect on dog itchiness, often cited as a most common complaint from dog owners. No significant side effects were reported by owners, and they all planned to continue treatment with the product for their dog.

"This is a really positive response since these dogs were all refractory to commonly used products. This can be a regimen that is safe and effective and is a worthwhile addition to the current regimen and could be considered a first line of defense and can be used in conjunction with other products when necessary,” expressed Chief Medical Officer of ElleVet Sciences, Joe Wakshlag says, PhD, DACVN, DACVSMR. “This study was a huge success and we at ElleVet are extremely excited to share the results with the veterinary community."

Advertisement

“The results are even better than we anticipated, and we are thrilled to be able to share these results and help dogs with this issue,” said Amanda Howland, co-founder of ElleVet Sciences.

"The dosing in the study was specific for atopic dermatitis, highlighting the need for accurate dosing in CBD+CBDA products,” Wakshlag concluded.2

To learn more or purchase the product, visit ElleVet Sciences’ website or find it through a veterinarian.

References

  1. Loewinger M, Wakshlag JJ, Bowden D, Peters-Kennedy J, Rosenberg A. The effect of a mixed cannabidiol and cannabidiolic acid based oil on client-owned dogs with atopic dermatitis. Vet Dermatol. 2022. doi: 10.1111/vde.13077.
  2. "Veterinary Dermatology" publishes results of ElleVet Sciences exclusive atopic dermatitis Study of proprietary CBD+CBDA oil on dogs. News release. ElleVet Sciences. June 2, 2022. Accessed June 6, 2022. https://www.prnewswire.com/news-releases/veterinary-dermatology-publishes-results-of-ellevet-sciences-exclusive-atopic-dermatitis-study-of-proprietary-cbdcbda-oil-on-dogs-301559759.html

Related Content:

DermatologyRolesAssociatesProductsIntegrative Medicine
New Automatic 2-in-1 Pet Feeder and Water Dispenser launched
New Automatic 2-in-1 Pet Feeder and Water Dispenser launched
Alternate therapies for pain management
Alternate therapies for pain management
dvm360® product report: One Health microsite, plus mushroom equine supplement and more
dvm360® product report: One Health microsite, plus mushroom equine supplement and more

Advertisement

Latest News

Drug for acute onset of canine pancreatitis is launched on the US market

New Automatic 2-in-1 Pet Feeder and Water Dispenser launched

PetHub launches AI tools for pet owners

Prairie dog pups emerge from underground at Maryland Zoo

View More Latest News
Advertisement